Our previous study showed that activated TBK1 induces obesity-induced ubiquitinated protein inclusions in liver tissue and that inhibiting the TBK1 pathway protects against fibrotic liver pathologies in mouse models of obesity and nonalcoholic steatohepatitis (21). This evidence concerns the gene TBK1 and obesity disorder.